Regional healthcare partnership SAJA Pharmaceuticals has formed a strategic JV between Tamer Industries and Japanese giants Daiichi Sankyo and Astellas, indicating strong regional collaboration and potential for co-developed or jointly distributed products in the Middle East and broader Gulf region.

MoU with UAA Recent memorandum of understanding and strategic partnership with the Urological Association of Asia in Dubai suggests opportunities to supply urology-focused pharmaceuticals, devices, or related solutions across a large and active clinical network.

Mid-market growth With estimated annual revenue in the 25 to 50 million USD range and a workforce approaching 5,000, SAJA sits in a scalable mid-market tier ripe for expanded product portfolios, contract manufacturing, and regional distribution partnerships.

Tech-enabled operations Adoption of cloud and data technologies (AWS, MySQL, Google Analytics) coupled with standard industry certifications (ISO) points to a digital-ready company capable of streamlined supply chain, demand forecasting, and performance analytics for sales enablement.

Strategic expansion readiness Partnerships with global leaders and a track record of regional MoUs indicate readiness for joint ventures, licensing deals, or exclusive distribution agreements that can unlock new market segments and accelerate penetration in hospitals, clinics, and government tenders.